Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001575650 | SCV001802696 | likely benign | not provided | 2019-07-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004026153 | SCV005008875 | likely benign | Inborn genetic diseases | 2023-09-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center of Medical Genetics, |
RCV000754535 | SCV000803247 | association | Autism spectrum disorder | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004547847 | SCV004733191 | likely benign | POGZ-related disorder | 2024-02-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |